Pregled bibliografske jedinice broj: 1279637
Molecular characterisation of colistin and carbapenem-resistant clinical isolates of Acinetobacter baumannii from Southeast Europe
Molecular characterisation of colistin and carbapenem-resistant clinical isolates of Acinetobacter baumannii from Southeast Europe // Journal of Global Antimicrobial Resistance, 33 (2023), 26-30 doi:10.1016/j.jgar.2023.02.019 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1279637 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Molecular characterisation of colistin and
carbapenem-resistant clinical isolates of
Acinetobacter baumannii from Southeast Europe
Autori
Goić-Barišić, Ivana ; Šeruga Musić, Martina ; Drčelić, Marina ; Tuncbilek, Semra ; Akca, Gulcin ; Jakovac, Sanja ; Tonkić, Marija ; Hrenović, Jasna
Izvornik
Journal of Global Antimicrobial Resistance (2213-7165) 33
(2023);
26-30
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Acinetobacter baumannii ; Colistin ; Carbapenems ; Hospital ; Resistance
Sažetak
Objectives: To characterise 11 colistin- and carbapenem-resistant Acinetobacter baumannii isolates recently emerging in hospital settings. Methods: A. baumannii isolates were collected from hospitalised patients under colistin treatment in three countries of Southeast Europe: Turkey, Croatia, and Bosnia and Herzegovina. Isolates were identified using molecular methods. Results: Isolates from Turkey and Croatia belong to the sequence types ST195 or ST281 of the clone lineage 2, while the single isolate from Bosnia and Herzegovina belongs to the ST231 of clone lineage 1. All isolates turned out to be highly resistant to colistin (MIC ≥ 16 mg/L) and have point mutations in pmrCAB operon genes. The colistin-resistant isolate from Bosnia and Herzegovina had a unique P170L point mutation in the pmrB gene and the R125H point mutation in the pmrC gene. The L20S mutation in the pmrA gene was detected only in isolates from Croatia and has never been reported before in isolates from this country. Conclusion: Colistin resistance in A. baumannii in hospitalised patients receiving colistin treatment is a result of chromosomal mutations. The pattern of point mutations in pmrCAB genes suggests a spread of specific colistin-resistant isolates within the hospital.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Prirodoslovno-matematički fakultet, Zagreb,
KBC Split,
Medicinski fakultet, Split
Profili:
Marija Tonkić
(autor)
Ivana Goić Barišić
(autor)
Jasna Hrenović
(autor)
Martina Šeruga Musić
(autor)
Marina Drčelić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE